share_log

Intuitive Surgical (NASDAQ:ISRG) Receives New Coverage From Analysts at William Blair

Intuitive Surgical (NASDAQ:ISRG) Receives New Coverage From Analysts at William Blair

直覺手術 (NASDAQ: ISRG) 在威廉·布萊爾獲得分析師的新報導
Financial News Live ·  2023/03/23 20:35

Equities research analysts at William Blair initiated coverage on shares of Intuitive Surgical (NASDAQ:ISRG – Get Rating) in a report released on Thursday, The Fly reports. The brokerage set an "outperform" rating on the medical equipment provider's stock.

威廉·布萊爾(William Blair)的股票研究分析師開始對 直觀的手術 (納斯達克:ISRG — 獲得評級) 在星期四發布的報告中,《蒼蠅》報告。經紀公司對醫療設備提供商的股票設定了「跑贏大市」評級。

A number of other analysts also recently issued reports on ISRG. Barclays lifted their target price on Intuitive Surgical from $235.00 to $298.00 in a research report on Wednesday, January 4th. StockNews.com started coverage on Intuitive Surgical in a research report on Thursday, March 16th. They set a "hold" rating on the stock. Argus boosted their price target on Intuitive Surgical from $265.00 to $320.00 and gave the stock a "buy" rating in a research report on Thursday, December 22nd. Mizuho lowered their price target on Intuitive Surgical from $245.00 to $240.00 in a research report on Wednesday, January 25th. Finally, BTIG Research lowered their price target on Intuitive Surgical from $316.00 to $279.00 and set a "buy" rating on the stock in a research report on Wednesday, January 25th. Six analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $273.83.

許多其他分析師最近也發表了有關 ISRG 的報告。1 月 4 日(週三)的一份研究報告中,巴克萊將直覺手術的目標價格從 235.00 美元提高至 298.00 美元。Stocknews.com 於 3 月 16 日(星期四)在一份研究報告中開始對直覺手術的報導。他們設置了股票的「持有」評級。阿格斯將直覺手術的價格目標從 265.00 美元提高到 320.00 美元,並在 12 月 22 日(星期四)的一份研究報告中給予該股票「買入」評級。瑞穗在 1 月 25 日(星期三)的一份研究報告中,將直覺手術的價格目標從 245.00 美元降至 240.00 美元。最後,BTIG 研究所將直覺手術的價格目標從 316.00 美元降低至 279.00 美元,並在 1 月 25 日(週三)的研究報告中設定了該股票的「買入」評級。六位分析師對該股票進行了保持評級,十三名分析師為該公司分配了買入評級。根據 MarketBeat.com 的數據,直觀手術目前的平均評級為「中等買入」,共識價格目標為 273.83 美元。

Get
取得
Intuitive Surgical
直觀的手術
alerts:
警報:

Intuitive Surgical Stock Performance

直觀的手術股票性能

NASDAQ:ISRG opened at $240.81 on Thursday. The stock's 50-day simple moving average is $242.81 and its 200 day simple moving average is $239.16. The company has a market cap of $84.35 billion, a P/E ratio of 65.80, a P/E/G ratio of 4.79 and a beta of 1.29. Intuitive Surgical has a 52-week low of $180.07 and a 52-week high of $308.97.

納斯達克:ISRG 在周四開業 240.81 美元。該股票的 50 天簡單移動平均線為 242.81 美元,其 200 日簡單移動平均線為 239.16 美元。該公司的市值為 84.35 億美元,市盈率為 65.80,市盈/克比率為 4.79,以及 1.29 的測試值。直覺式外科手術的價格為 52 週低點 180.07 美元,而 52 週的高位則為 308.97 美元。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its earnings results on Tuesday, January 24th. The medical equipment provider reported $1.23 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.25 by ($0.02). The company had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.66 billion. Intuitive Surgical had a net margin of 21.25% and a return on equity of 11.27%. Intuitive Surgical's revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.30 EPS. As a group, equities analysts predict that Intuitive Surgical will post 4.21 earnings per share for the current fiscal year.

直觀的手術(NASDAQ:ISRG-獲取評級)最後一次發布了其收益結果,週二,1 月 24 日。醫療設備提供商報告了本季度每股盈利 1.23 美元,缺失分析師的共識估計為 1.25 美元(0.02 美元)。該公司在本季度的營收為 1.66 億美元,而分析師估計為 66 億美元。直覺手術的淨利潤率為 21.25%,股本回報率為 11.27%。直覺手術的收入與去年同季度相比增長了 6.7%。在上一年同期,該公司每股收益 1.30 美元。作為一個集團,股票分析師預測,直覺外科將公佈當前財政年度的每股收益 4.21。

Insider Activity at Intuitive Surgical

直觀手術的內幕活動

In related news, EVP David J. Rosa sold 45,025 shares of the business's stock in a transaction that occurred on Monday, February 6th. The stock was sold at an average price of $250.53, for a total value of $11,280,113.25. Following the completion of the sale, the executive vice president now directly owns 125,385 shares in the company, valued at $31,412,704.05. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, VP Fredrik Widman sold 116 shares of the business's stock in a transaction that occurred on Thursday, February 16th. The stock was sold at an average price of $240.77, for a total value of $27,929.32. Following the completion of the sale, the vice president now directly owns 1,605 shares in the company, valued at $386,435.85. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP David J. Rosa sold 45,025 shares of the business's stock in a transaction that occurred on Monday, February 6th. The shares were sold at an average price of $250.53, for a total transaction of $11,280,113.25. Following the transaction, the executive vice president now owns 125,385 shares of the company's stock, valued at $31,412,704.05. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 82,396 shares of company stock worth $20,438,478. Company insiders own 0.90% of the company's stock.

在相關新聞中,執行副總裁戴維 ·J· 羅莎在 2 月 6 日(星期一)發生的交易中出售了該業務股票的 45,025 股。該股票以 250.53 美元的平均價格出售,總價值為 11,280,113.25 美元。出售完成後,執行副總裁目前直接擁有該公司 125,385 股股份,價值 31,412,704.05 美元。銷售在與 SEC 提交的文件中披露,該文件可在 這個鏈接。在相關新聞中,副總裁弗雷德里克·威德曼在 2 月 16 日(星期四)發生的交易中出售了該企業股票的 116 股。該股票以 240.77 美元的平均價格出售,總價值為 27,929.32 美元。出售完成後,副總裁現在直接擁有該公司的 1,605 股股份,價值 386,435.85 美元。銷售在與 SEC 提交的文件中披露,該文件可在 這個鏈接。此外,執行副總裁大衛 ·J· 羅莎在 2 月 6 日(星期一)發生的交易中出售了該企業股票的 45,025 股。這些股票以 250.53 美元的平均價格出售,交易總額為 11,280,113.25 美元。交易完成後,執行副總裁現擁有該公司股票的 125,385 股股份,價值 31,412,704.05 美元。可以找到此次銷售的披露 這裡。在過去九十天內,內部人士出售了 82,396 股價值 20,438,478 美元的公司股票。公司內部人士擁有公司股票的 0.90%。

Institutional Inflows and Outflows

機構流入和流出

Several institutional investors have recently added to or reduced their stakes in ISRG. RB Capital Management LLC raised its position in Intuitive Surgical by 4.4% during the first quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider's stock valued at $523,000 after purchasing an additional 73 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in Intuitive Surgical by 0.6% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 946,709 shares of the medical equipment provider's stock valued at $285,603,000 after purchasing an additional 5,233 shares in the last quarter. Baird Financial Group Inc. raised its position in Intuitive Surgical by 2.3% during the first quarter. Baird Financial Group Inc. now owns 21,089 shares of the medical equipment provider's stock valued at $6,362,000 after purchasing an additional 481 shares in the last quarter. Brown Brothers Harriman & Co. raised its position in Intuitive Surgical by 576.7% during the first quarter. Brown Brothers Harriman & Co. now owns 406 shares of the medical equipment provider's stock valued at $122,000 after purchasing an additional 346 shares in the last quarter. Finally, Covestor Ltd raised its position in Intuitive Surgical by 50.4% during the first quarter. Covestor Ltd now owns 418 shares of the medical equipment provider's stock valued at $126,000 after purchasing an additional 140 shares in the last quarter. 81.96% of the stock is currently owned by institutional investors and hedge funds.

一些機構投資者最近增加或減少了他們在 ISRG 的股份。RB 資本管理有限責任公司在第一季度將其在直覺外科中的地位提高了 4.4%。RB 資本管理有限責任公司現在擁有該醫療設備提供商的 1,735 股股票,價值為 523,000 美元,在上個季度額外購買 73 股後。未來資產環球投資有限公司在第一季度,Ltd. 在直覺手術中提高了 0.6% 的地位。未來資產環球投資有限公司在上一季度額外購買 5,233 股股份後,Ltd. 目前擁有該醫療器材提供商股票價值 285,603,000 美元的 946,709 股。貝爾德金融集團股份有限公司在第一季度提高了 2.3% 的直覺手術地位。貝爾德金融集團股份有限公司現在擁有該醫療設備提供商的 21,089 股股票,價值 6,362,000 美元,在上一季度額外購買 481 股股票後。布朗兄弟哈里曼 & 有限公司. 在第一季度提高了其直觀外科的地位 576.7%.布朗兄弟哈里曼公司在上一季度額外購買 346 股後,現在擁有 406 股價值 122,000 美元的醫療設備提供商股票。最後,科維斯特有限公司在第一季度將其在直覺手術中的地位提高了 50.4%。科維斯特有限公司在上一季度額外購買 140 股股票後,現在擁有該醫療設備提供商的 418 股股票,價值為 126,000 美元。81.96% 的股票目前由機構投資者和對沖基金擁有。

Intuitive Surgical Company Profile

直觀的外科公司簡介

(Get Rating)

(取得評分)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.

直覺式外科, Inc. 透過全面的產品和服務生態系統,致力於提供機器人輔助手術解決方案和侵入性護理。其產品包括達文西外科手術和離子內光系統。該公司由弗雷德里克 ·H· 莫爾成立, 約翰·戈登·弗羅因德, 和羅伯特摹.

Further Reading

進一步閱讀

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • Why Wall Street Loves These 3 Penny Stocks
  • Low Volume Bunge Plunge Presents an Opportunity
  • Carvana May Be Able To Reach Profitability This Year
  • 3 Leading Dividend Stocks Expected To Grow Earnings
  • Are Homebuilders Ready To Rally If Fed Rate Hikes Slow?
  • 獲取有關直覺手術研究報告的免費副本
  • 為什麼華爾街喜歡這 3 竹篙股票
  • 低容量邦吉暴跌提出了機會
  • 卡瓦納今年可能能夠達到盈利能力
  • 3 個領先股息股票預計將增長盈利
  • 如果美聯儲加息緩慢,房屋建築商是否準備好反彈?

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接收每日直觀手術的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收直觀手術和相關公司的最新新聞和分析師評級的簡要每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論